Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment

Myelodysplastic syndromes (MDS) are a group of clonal hematological neoplasms characterized by ineffective hematopoiesis in one or more bone marrow cell lineages. Consequently, patients present with variable degrees of cytopenia and dysplasia. These characteristics constitute the basis for the World...

Full description

Bibliographic Details
Main Authors:	Pamela Acha, Mar Mallo, Francesc Solé
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Cancers
Subjects:	myelodysplastic syndromes chromosome 5q deletion somatic mutations cytogenetic alterations
Online Access:	https://www.mdpi.com/2072-6694/14/22/5531

Similar Items

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype
by: Mar Mallo, et al.
Published: (2023-05-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
by: Mohammad Faizan Zahid, et al.
Published: (2016-12-01)

The der(1;7)(q10;p10) defining a distinct profile from −7/del(7q) in myelodysplastic syndromes: A systematic review and meta‐analysis
by: Wei Lang, et al.
Published: (2024-01-01)

Erythrophagocytosis by neutrophils and megakaryocytic emperipolesis are distinctive morphologic features in del(20q)-associated myelodysplastic syndrome
by: Min Shi, MD, PhD, et al.
Published: (2017-06-01)

Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical–Biological Entity?
by: Alessia Campagna, et al.
Published: (2022-05-01)

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion
by: Martín I. Castillo, et al.
Published: (2023-08-01)

Myelodysplastic Syndrome with 6q Deletion as the Sole Chromosome Abnormality in an Iranian Patient: A Case Report with Review of Literature.
by: Shirin Ferdowsi, et al.
Published: (2013-10-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
by: Minh Phuong Vu, et al.
Published: (2022-01-01)

The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?
by: Michael R. Cook, et al.
Published: (2022-02-01)

Long-term hematological response in 5q- syndrome after lenalidomide suspension and further improvement by deferasirox.
by: Pasquale Niscola
Published: (2014-08-01)

A case of myelodysplastic syndrome with t(10;18)(q26;q21)
by: Yusuke Ohba, et al.
Published: (2019-10-01)

Myelodysplastic Syndrome: Diagnosis and Screening
by: Francisco P. Tria, et al.
Published: (2022-06-01)

Multi‐institutional experience of genetic diagnosis in Ecuador: National registry of chromosome alterations and polymorphisms
by: César Paz‐y‐Miño, et al.
Published: (2020-02-01)

<i>JAK2</i> Mutations Are Rare and Diverse in Myelodysplastic Syndromes: Case Series and Review of the Literature
by: Melissa Delio, et al.
Published: (2023-01-01)

Favorable prognostic phenotype in myelodysplastic syndrome with der(1;7)(q10;p10)
by: Tomohiro Horio, et al.
Published: (2020-11-01)

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach
by: Pamela Acha, et al.
Published: (2021-02-01)

Clinicohematological and cytogenetic profile of myelodysplastic syndromes in Pakistan-compare and contrast
by: Nida Anwar, et al.
Published: (2017-05-01)

Development and validation of a novel prognosis prediction model for patients with myelodysplastic syndrome
by: Haiping Liang, et al.
Published: (2022-10-01)

Novel Therapies for Unmet Clinical Needs in Myelodysplastic Syndromes
by: Giulio Cassanello, et al.
Published: (2022-10-01)

Concurrent Waldenstrom’s Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation
by: Peter A. DeRosa, et al.
Published: (2022-06-01)

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
by: Anne Jouinot, et al.
Published: (2020-08-01)

Patients of Myelodysplastic Syndrome with Mild/Moderate Myelofibrosis and a Monosomal Karyotype are Independently Associated with an Adverse Prognosis: Long-Term Follow-Up Data
by: Wang N, et al.
Published: (2020-07-01)

Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients
by: Mostafa Paridar, et al.
Published: (2021-05-01)

Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q
by: Vera Adema, et al.
Published: (2022-06-01)

Distinct Clinical and Prognostic Features of Myelodysplastic Syndrome in Patients from the Middle East, North Africa, and Beyond: A Systemic Review
by: Amal Al-Haidose, et al.
Published: (2023-04-01)

Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
by: Bruno Fattizzo, et al.
Published: (2022-03-01)

Genetic Characteristics of Patients with Young-Onset Myelodysplastic Neoplasms
by: Hyun-Young Kim, et al.
Published: (2023-12-01)

Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation
by: Olga Blau, et al.
Published: (2016-11-01)

Coexistence of myelodysplastic syndrome and acute megakaryoblastic leukemia: An aggressive disease
by: Ganesh Kasinathan, et al.
Published: (2021-06-01)

Somatic genomic variants in refractory cytopenia of childhood
by: Diego F. Coutinho, et al.
Published: (2021-09-01)

Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment
by: Fabiana Kalina Marques, et al.
Published: (2022-12-01)

Myelodysplastic Syndrome in Pakistan: Clinicohematological Characteristics, Cytogenetic Profile, and Risk Stratification
by: Rafia Mahmood, et al.
Published: (2018-05-01)

A Novel Constitutional t(3;8)(p26;q21) and <i>ANKRD26</i> and <i>SRP72</i> Variants in a Child with Myelodysplastic Neoplasm: Clinical Implications
by: Viviane Lamim Lovatel, et al.
Published: (2023-04-01)

Asian Population Is More Prone to Develop High-Risk Myelodysplastic Syndrome, Concordantly with Their Propensity to Exhibit High-Risk Cytogenetic Aberrations
by: Yan Jiang, et al.
Published: (2021-01-01)

Long-Term Response in a Patient with del(5q) Myelodysplastic Syndrome Who Discontinued Lenalidomide and Obtained a Good Response and Tolerance to Rechallenge
by: Francesco Pisani, et al.
Published: (2014-04-01)

Interstitial deletion of 5q33.3q35.1 in a boy with severe mental retardation
by: Jin Hwan Lee, et al.
Published: (2016-11-01)

Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
by: Tzu-Hua Chen-Liang
Published: (2021-05-01)

Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms
by: Xiangzong Zeng, et al.
Published: (2024-04-01)

Spontaneous chromatid break as clonal evolution in myelodysplastic syndrome patients
by: Daniela P. Borges, et al.
Published: (2017-11-01)